Evaluation of transurethral vaporization of prostate with pressure-flow analysis and other clinical measures

Journal of Endourology

Volumn 10, Issue 5, 1996, Pages 469-472

  Burney, Tracy L ^a   Desautel, Michael G ^a   Badlani, Gopal H ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER PRESSURE; CLINICAL ARTICLE; DETRUSOR MUSCLE; FOLLOW UP; HUMAN; LASER SURGERY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; RESIDUAL VOLUME; STENOSIS; SYMPTOM; TREATMENT OUTCOME; URINE FLOW RATE; URINE RETENTION; UROFLOWMETRY; VAPORIZATION;

EID: 0029853994     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.1996.10.469     Document Type: Article

References (28)

1. Kaplan SA, Te AE: Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995;45:566-572
2. Stewart SC, Benjamin D, Ruckle H, Lui P, Hadley R: Electrovaporization of the prostate: new technique for treatment of symptomatic benign hyperplasia. J Endourol 1995;9:413-416
3. Baert L, Willemen P, Ameye F, Petrovich Z: Treatment response with transurethral microwave hyperthermia in different forms of benign prostatic hyperplasia: a preliminary report. Prostate 1991;18:315-320
4. Blute ML, Tomera KM, Hellerstein DK, McKiel CF, Lynch JH, Regan JB, Sankey NE: Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prestation Cooperative Study. J Urol 1993;150:1591-1596
5. Costello AJ, Howsher WG, Bolton DM: Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992;69:603-608
6. Kabalin JN: Laser prostatectomy performed with a right angle firing neodynium: YAG laser fiber at 40 watts power setting. J Urol 1993;150:95-99
7. Leach GE, Sirls LT, Ganabathi K: Outpatient visual laser-assisted prostatectomy under local anesthesia. Urology 1994;10:149-153
8. Lepor H, Sypherd D, Machi G, Derus J: Randomized double blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1992;147:639-642
9. Lindner A, Braf Z, Lev A, Golomb J, Leib Z, Siegel Y, Servadia C: Local hyperthermia of the prostate gland for the treatment of symptomatic benign prostatic hypertrophy and urinary retention. Br J Urol 1990;65:201-203
10. Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M: Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol 1993;23(suppl 1):39-43
11. Malloy TR, Carpiniello VL. Wein AJ, Payne C, Wuchinich D: Bladder outlet obstruction treated with transurethral ultrasonic aspiration: one-year follow-up on 59 patients. Urology 1991;37: 512-515
12. Narayan P, Fournier G, Indudhara R, Leidich R, Shinohara K, Ingerman A: Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Urology 1994;43: 813-820
13. Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB: The North American experience with the Urolume endoprosthesis as a treatment for benign prostatic hyperplasia: long term results. Urology 1994;44:353-362
14. Weiss JN, Badlani GH, Ravalli R, Manne J, Smith AD: Urodynamic and symptomatic effects of balloon dilation of the prostate. J Endourol 1991;5:105-107
15. Abrams P: In support of pressure-flow studies for evaluation men with lower urinary tract symptoms. Urology 1994;44:153-155
16. McConnell JD: Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia. Urology 1994;44:156-158
17. Kaplan SA, Te AE: Uroflowmetry and urodynamics. Urol Clin North Am 1995;22:309-320
18. Milam DF, Smith JA: Laser prostatectomy devices and their tissue effects. J Endourol 1995;9:85-88
19. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC: Transurethral prostatectomy: immediate and postoperative complications: a co-operative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-247
20. Gormley GJ, Stoner E, Bruskewitz RC, et al: The effect of finasteride in men with benign prostatic hyperplasia: The Finasteride Study Group. N Engl J Med 1992;327:1185-1191
21. Lepor H, Auerbach S, Puras-Baez A, et al: A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 1992; 148:1467-1474
22. Peters CA, Walsh PC: The effect of nafarelin acetate, a luteinizing hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 1987;317:599-604
23. Schweikert HU, Tunn UW: Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia. Steroids 1987; 50:191-200
24. Stone NN: Flutamide in treatment of benign prostatic hypertrophy. Urology 1989;34(suppl 4):64-68
25. Larson TR: Rollerball electrovaporization of the prostate, is it safe? intraprostatic thermometry during rollerball surgery (abstract). J Endourol 1995;9(suppl 1):58A
26. Perlmutter AP, Muschter R, Razvi HA: Electrosurgical vaporization of the prostate in the canine model. Urology 1995;46:518-523
27. Talja M, Tammela T, Petas A, Valimaa T, Taari K, Viherkoski E, Tormala P: Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy. J Urol 1995;154:2089-2092
28. Haag R, Cuschieri A: Recent advances in high-frequency electrosurgery: development of automated systems. J R Coll Surg Edinburgh 1993;38:354-364